Shots:
Samsara Biocapital is a California-based venture capital and registered investment adviser investing across early to post-IPO stages in healthcare, life sciences, oncology, and digital health, with a portfolio of 70+ companies including Scholar Rock and PepGen
The firm made 30 investments across PIPE (43%), Series B (23%), and other rounds, with notable deals such…
Shots:
Welcome to the September edition of Know Your Investor, featuring leading investors fuelling healthcare & life sciences
This edition spotlights Cormorant Asset Management, an investment firm focused on biotechnology and healthcare companies
In 2024, Cormorant completed 31 investments ~$3.88B, spanning PIPEs, private financings, IPO, and venture rounds. For the full report, contact us at…
Shots:
Welcome to the August edition of Know Your Investor, featuring leading venture capital firms fuelling innovation in healthcare and life sciences
This edition spotlights Venrock Healthcare Capital Partners, a venture capital fund focused on investments in both publicly and privately held healthcare companies
In 2024, Venrock Healthcare Capital Partners invested approximately $4.56B across six…
Shots:
Welcome to the 2025 edition of Know Your Investor, highlighting top venture capital firms driving healthcare innovation
This edition features Deep Track Capital, a firm dedicated to investing in life sciences companies that are advancing innovations to improve public health
In 2024, Deep Track Capital invested approximately $4.35B across six funding rounds, adding 32…
Shots:
Welcome to the 2025 edition of Know Your Investor, spotlighting leading venture capital firms driving innovation in healthcare.
This edition features Alexandria Venture Investments, a firm committed to supporting disruptive life science companies that aim to improve human health.
In 2024, the firm invested approximately $2.7B across six public and private funding rounds, adding…
Shots:
Welcome to the 2025 series of Know Your Investor, featuring top venture capital firms focused on healthcare.
This edition highlights Janus Henderson Group Plc, a global investment firm managing approximately $378.7B in assets across Equities, Fixed Income, Multi-Asset, and Alternatives.
In 2024, the firm invested $5.36B across six funding rounds, adding 39 healthcare and…
Shots:
The February edition highlights OrbiMed Advisors, a New York-based investment firm specializing in public and private investments within the healthcare and biotech sectors
In 2024, OrbiMed expanded its portfolio by adding 49 companies, investing approximately $6.08B across five funding rounds, including private and debt financing
For the complete report, contact us at connect@pharmashots.com
OrbiMed primarily…
Shots:
The January Edition features RA Capital Management, a global multi-stage investment firm dedicated to healthcare and life sciences
In 2024, RA Capital added 74 companies to its portfolio, investing approximately $8.5B across seven funding rounds, including private and common funding
Welcome to the 2025 series of Know Your Investor, a meticulously crafted report highlighting…
Shots:
A California-based venture capital fund, Samsara Biocapital partners with medical companies and scientists to infuse cutting-edge innovations in medicines
In 2023, Samsara participated in five funding rounds and invested around $2.3B to add 19 companies to its portfolio
For a curated report on a specific investor or venture capital, reach out to us at connect@pharmashots.com …
Shots:
An equity hedge fund manager company, BVF Partners invests in small cap and early-stage biotechnology companies
In 2023, BVF participated in five investment rounds and added 20 companies to its portfolio
For a curated report on a specific investor or venture capital, reach out to us at connect@pharmashots.com
Established in 1993 in San Francisco, California,…

